Healthcare Sector Stocks
The Healthcare sector has a total of 1063 stocks, with a combined market cap of $8.16 trillion, total revenue of $4.59 trillion and a weighted average PE ratio of 40.68.
Market Cap
8.16T
Revenue
4.59T
Profits
200.69B
PE Ratio
40.68
Profit Margin
4.37%
Dividend Yield
0.44%
1063 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 896.13B | - | 2,820,727 | 72.25B |
| 2 | JNJ | Johnson & Johnson | 545.74B | -1.77% | 12,166,950 | 96.36B |
| 3 | ABBV | AbbVie Inc. | 371.72B | -0.18% | 5,385,048 | 62.82B |
| 4 | UNH | UnitedHealth Group Incorporated | 357.67B | -1.31% | 9,811,194 | 449.71B |
| 5 | NVS | Novartis AG | 282.97B | -1.13% | 829,344 | 56.58B |
| 6 | AZN | AstraZeneca PLC | 281.66B | -1.83% | 1,379,471 | 60.44B |
| 7 | MRK | Merck & Co., Inc. | 275.09B | -1.79% | 10,028,864 | 65.77B |
| 8 | NVO | Novo Nordisk A/S | 207.87B | -2.31% | 16,383,758 | 50.57B |
| 9 | AMGN | Amgen Inc. | 176.11B | - | 3,447,805 | 37.22B |
| 10 | TMO | Thermo Fisher Scientific Inc. | 162.90B | -2.20% | 2,038,091 | 45.20B |
| 11 | GILD | Gilead Sciences, Inc. | 160.88B | -1.88% | 6,641,026 | 29.74B |
| 12 | ISRG | Intuitive Surgical, Inc. | 149.15B | -1.62% | 2,375,097 | 10.58B |
| 13 | ABT | Abbott Laboratories | 147.13B | -0.51% | 13,208,557 | 45.13B |
| 14 | PFE | Pfizer Inc. | 144.37B | -1.63% | 37,110,084 | 63.32B |
| 15 | CVS | CVS Health Corporation | 122.35B | -1.30% | 8,798,380 | 405.62B |
| 16 | SYK | Stryker Corporation | 117.60B | 0.41% | 3,595,131 | 25.27B |
| 17 | BMY | Bristol-Myers Squibb Company | 116.40B | 0.41% | 10,824,329 | 48.48B |
| 18 | DHR | Danaher Corporation | 114.60B | -1.60% | 4,053,983 | 24.78B |
| 19 | VRTX | Vertex Pharmaceuticals Incorporated | 110.90B | -2.99% | 1,288,893 | 12.22B |
| 20 | SNY | Sanofi | 103.16B | -0.37% | 2,689,689 | 54.60B |
| 21 | GSK | GSK plc | 99.05B | - | 3,915,138 | 43.29B |
| 22 | MDT | Medtronic plc | 97.77B | -1.07% | 9,127,304 | 35.48B |
| 23 | HCA | HCA Healthcare, Inc. | 93.84B | -2.24% | 1,156,113 | 76.39B |
| 24 | MCK | McKesson Corporation | 91.42B | 1.79% | 1,534,439 | 403.43B |
| 25 | ELV | Elevance Health, Inc. | 85.28B | -1.02% | 1,972,953 | 200.42B |
| 26 | BSX | Boston Scientific Corporation | 78.30B | -1.62% | 14,843,340 | 20.61B |
| 27 | CI | The Cigna Group | 75.46B | -3.28% | 2,178,005 | 277.89B |
| 28 | REGN | Regeneron Pharmaceuticals, Inc. | 71.04B | -2.05% | 728,233 | 14.92B |
| 29 | TAK | Takeda Pharmaceutical Company Limited | 52.26B | -0.12% | 2,789,063 | 28.34B |
| 30 | COR | Cencora, Inc. | 50.14B | - | 2,708,169 | 328.68B |
| 31 | ARGX | argenx SE | 50.10B | -2.77% | 326,419 | 4.74B |
| 32 | MDLN | Medline Inc. | 47.54B | -6.97% | 7,380,226 | 29.14B |
| 33 | EW | Edwards Lifesciences Corporation | 46.86B | 0.05% | 4,672,978 | 6.30B |
| 34 | CAH | Cardinal Health, Inc. | 45.72B | 0.42% | 3,715,527 | 250.74B |
| 35 | IDXX | IDEXX Laboratories, Inc. | 41.71B | -0.76% | 659,262 | 4.45B |
| 36 | TEVA | Teva Pharmaceutical Industries Limited | 39.93B | -2.89% | 6,694,884 | 17.35B |
| 37 | BDX | Becton, Dickinson and Company | 39.53B | -0.69% | 4,277,333 | 22.23B |
| 38 | HLN | Haleon plc | 39.37B | 0.56% | 9,067,600 | 14.85B |
| 39 | ALNY | Alnylam Pharmaceuticals, Inc. | 38.32B | -2.20% | 1,149,641 | 4.29B |
| 40 | HUM | Humana Inc. | 36.63B | 1.25% | 1,975,954 | 137.20B |
| 41 | ONC | BeOne Medicines AG | 32.60B | -3.73% | 269,815 | 5.70B |
| 42 | WAT | Waters Corporation | 32.32B | -1.20% | 856,359 | 3.77B |
| 43 | A | Agilent Technologies, Inc. | 31.57B | -1.38% | 1,413,358 | 7.07B |
| 44 | ALC | Alcon Inc. | 31.25B | -0.56% | 2,131,748 | 10.63B |
| 45 | ZTS | Zoetis Inc. | 31.12B | -1.67% | 8,951,993 | 9.53B |
| 46 | RVMD | Revolution Medicines, Inc. | 30.97B | -2.55% | 2,475,769 | - |
| 47 | RPRX | Royalty Pharma plc | 30.43B | - | 4,264,784 | 2.44B |
| 48 | RMD | ResMed Inc. | 29.28B | -0.29% | 1,405,680 | 5.54B |
| 49 | CNC | Centene Corporation | 28.77B | -0.73% | 4,662,709 | 178.33B |
| 50 | BIIB | Biogen Inc. | 28.49B | 0.83% | 1,252,271 | 9.94B |
| 51 | IQV | IQVIA Holdings Inc. | 28.23B | -0.91% | 1,791,080 | 16.63B |
| 52 | GEHC | GE HealthCare Technologies Inc. | 27.64B | -3.05% | 4,777,452 | 20.98B |
| 53 | NTRA | Natera, Inc. | 26.69B | -5.36% | 2,239,959 | 2.50B |
| 54 | VEEV | Veeva Systems Inc. | 25.93B | 1.67% | 2,095,461 | 3.20B |
| 55 | PHG | Koninklijke Philips N.V. | 24.16B | -1.06% | 1,219,970 | 20.34B |
| 56 | UTHR | United Therapeutics Corporation | 24.13B | -1.25% | 334,197 | 3.17B |
| 57 | DXCM | DexCom, Inc. | 23.78B | 6.59% | 11,133,391 | 4.82B |
| 58 | INSM | Insmed Incorporated | 23.66B | -5.60% | 3,688,413 | 819.56M |
| 59 | BNTX | BioNTech SE | 22.65B | -2.65% | 1,169,141 | 3.23B |
| 60 | ILMN | Illumina, Inc. | 21.57B | -0.49% | 1,770,155 | 4.39B |
| 61 | WST | West Pharmaceutical Services, Inc. | 21.40B | 0.90% | 686,425 | 3.22B |
| 62 | ROIV | Roivant Sciences Ltd. | 20.96B | -0.71% | 7,211,633 | 13.31M |
| 63 | MTD | Mettler-Toledo International Inc. | 20.85B | -0.99% | 204,115 | 4.09B |
| 64 | STE | STERIS plc | 20.80B | -1.79% | 1,392,306 | 5.94B |
| 65 | DGX | Quest Diagnostics Incorporated | 20.66B | -0.71% | 1,081,530 | 11.28B |
| 66 | LH | Labcorp Holdings Inc. | 20.53B | -1.43% | 568,669 | 14.14B |
| 67 | MRNA | Moderna, Inc. | 19.46B | -1.98% | 7,233,073 | 2.23B |
| 68 | VTRS | Viatris Inc. | 19.19B | -4.52% | 9,829,351 | 14.56B |
| 69 | INCY | Incyte Corporation | 19.04B | -2.38% | 1,648,991 | 5.36B |
| 70 | THC | Tenet Healthcare Corporation | 16.94B | -0.95% | 1,657,788 | 21.46B |
| 71 | GMAB | Genmab A/S | 16.20B | -1.34% | 1,362,310 | 3.90B |
| 72 | ZBH | Zimmer Biomet Holdings, Inc. | 16.19B | 1.27% | 2,578,905 | 8.41B |
| 73 | NBIX | Neurocrine Biosciences, Inc. | 15.93B | -0.40% | 1,307,348 | 3.10B |
| 74 | ASND | Ascendis Pharma A/S | 14.94B | -2.03% | 471,348 | 998.25M |
| 75 | JAZZ | Jazz Pharmaceuticals plc | 14.35B | -0.99% | 1,346,297 | 4.44B |
| 76 | RGC | Regencell Bioscience Holdings Limited | 14.13B | 6.21% | 119,752 | - |
| 77 | SMMT | Summit Therapeutics Inc. | 13.09B | -7.00% | 2,673,146 | - |
| 78 | BBIO | BridgeBio Pharma, Inc. | 12.95B | -5.07% | 2,679,213 | 579.96M |
| 79 | SOLV | Solventum Corporation | 12.86B | -0.21% | 1,667,755 | 8.26B |
| 80 | DVA | DaVita Inc. | 12.82B | 3.72% | 700,063 | 13.84B |
| 81 | PEN | Penumbra, Inc. | 12.68B | -0.20% | 443,675 | 1.45B |
| 82 | SNN | Smith & Nephew plc | 12.65B | -0.61% | 796,415 | 6.16B |
| 83 | EXEL | Exelixis, Inc. | 12.60B | -1.90% | 2,069,205 | 2.38B |
| 84 | GH | Guardant Health, Inc. | 12.59B | -3.79% | 1,771,436 | 1.08B |
| 85 | IONS | Ionis Pharmaceuticals, Inc. | 12.27B | -1.92% | 2,119,183 | 1.06B |
| 86 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.07B | -3.00% | 222,474 | 1.13B |
| 87 | BTSG | BrightSpring Health Services, Inc. | 11.91B | -0.86% | 2,833,442 | 13.65B |
| 88 | MEDP | Medpace Holdings, Inc. | 11.86B | -0.93% | 286,762 | 2.68B |
| 89 | AXSM | Axsome Therapeutics, Inc. | 11.72B | -1.96% | 549,549 | 708.24M |
| 90 | COO | The Cooper Companies, Inc. | 11.63B | -1.28% | 2,081,289 | 4.15B |
| 91 | FMS | Fresenius Medical Care AG | 11.62B | 0.61% | 674,484 | 22.32B |
| 92 | RDY | Dr. Reddy's Laboratories Limited | 11.60B | 0.89% | 2,265,747 | 3.58B |
| 93 | ALGN | Align Technology, Inc. | 11.26B | -2.04% | 923,641 | 4.10B |
| 94 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.80B | -3.79% | 1,746,962 | 622.01M |
| 95 | EHC | Encompass Health Corporation | 10.58B | -0.62% | 708,777 | 6.07B |
| 96 | RVTY | Revvity, Inc. | 10.48B | -2.50% | 1,171,312 | 2.90B |
| 97 | GMED | Globus Medical, Inc. | 10.40B | -0.74% | 1,367,562 | 3.10B |
| 98 | CYTK | Cytokinetics, Incorporated | 10.30B | -3.55% | 1,829,793 | 105.82M |
| 99 | ENSG | The Ensign Group, Inc. | 10.30B | -0.89% | 526,802 | 5.27B |
| 100 | PODD | Insulet Corporation | 10.21B | -0.82% | 1,441,879 | 2.90B |
| 101 | UHS | Universal Health Services, Inc. | 10.21B | -1.19% | 1,097,614 | 17.76B |
| 102 | BMRN | BioMarin Pharmaceutical Inc. | 10.01B | -2.69% | 2,076,143 | 3.24B |
| 103 | ELAN | Elanco Animal Health Incorporated | 9.92B | -8.23% | 7,849,467 | 4.89B |
| 104 | MOH | Molina Healthcare, Inc. | 9.64B | -0.97% | 879,077 | 43.10B |
| 105 | PRAX | Praxis Precision Medicines, Inc. | 9.55B | -0.85% | 343,675 | 7.46M |
| 106 | MASI | Masimo Corporation | 9.35B | 0.07% | 662,233 | 1.56B |
| 107 | ABVX | ABIVAX Société Anonyme | 9.11B | -5.35% | 943,932 | 5.37M |
| 108 | KRYS | Krystal Biotech, Inc. | 9.03B | -3.16% | 316,531 | 417.30M |
| 109 | BAX | Baxter International Inc. | 8.93B | -2.70% | 5,357,054 | 11.32B |
| 110 | ICLR | ICON Public Limited Company | 8.89B | -0.61% | 643,447 | 8.10B |
| 111 | GKOS | Glaukos Corporation | 8.45B | 1.31% | 978,750 | 551.35M |
| 112 | IBRX | ImmunityBio, Inc. | 8.35B | -2.21% | 11,347,555 | 140.98M |
| 113 | HSIC | Henry Schein, Inc. | 8.28B | 0.15% | 3,096,346 | 13.38B |
| 114 | NUVL | Nuvalent, Inc. | 8.08B | -2.02% | 798,512 | - |
| 115 | HALO | Halozyme Therapeutics, Inc. | 7.96B | -3.02% | 2,144,688 | 1.51B |
| 116 | TEM | Tempus AI, Inc. | 7.89B | -3.41% | 5,731,228 | 1.36B |
| 117 | PCVX | Vaxcyte, Inc. | 7.56B | -2.13% | 1,294,466 | - |
| 118 | ATR | AptarGroup, Inc. | 7.32B | -2.81% | 446,966 | 3.87B |
| 119 | CRL | Charles River Laboratories International, Inc. | 7.27B | -5.20% | 1,397,567 | 4.03B |
| 120 | OSCR | Oscar Health, Inc. | 7.02B | 0.73% | 8,562,291 | 13.30B |
| 121 | HQY | HealthEquity, Inc. | 6.94B | -0.18% | 843,813 | 1.31B |
| 122 | QGEN | Qiagen N.V. | 6.82B | -0.93% | 1,803,429 | 2.10B |
| 123 | TECH | Bio-Techne Corporation | 6.78B | -3.22% | 5,229,694 | 1.21B |
| 124 | KYMR | Kymera Therapeutics, Inc. | 6.76B | -2.71% | 468,276 | 51.48M |
| 125 | CELC | Celcuity Inc. | 6.65B | 2.20% | 1,476,453 | - |
| 126 | BIO | Bio-Rad Laboratories, Inc. | 6.62B | 0.51% | 374,679 | 2.59B |
| 127 | PTGX | Protagonist Therapeutics, Inc. | 6.57B | -3.19% | 560,751 | 74.06M |
| 128 | BRKR | Bruker Corporation | 6.53B | -2.90% | 2,776,756 | 3.46B |
| 129 | SYRE | Spyre Therapeutics, Inc. | 6.51B | -0.96% | 1,958,724 | - |
| 130 | GRFS | Grifols, S.A. | 6.47B | -1.67% | 461,950 | 8.58B |
| 131 | ALKS | Alkermes plc | 6.25B | -2.29% | 1,315,692 | 1.56B |
| 132 | MIRM | Mirum Pharmaceuticals, Inc. | 6.23B | -8.26% | 1,672,700 | 569.61M |
| 133 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.20B | -3.32% | 576,721 | 217.17M |
| 134 | CNTA | Centessa Pharmaceuticals plc | 6.13B | -0.03% | 533,372 | 15.00M |
| 135 | LNTH | Lantheus Holdings, Inc. | 6.11B | -2.86% | 926,932 | 1.55B |
| 136 | APGE | Apogee Therapeutics, Inc. | 6.08B | -3.30% | 714,815 | - |
| 137 | CORT | Corcept Therapeutics Incorporated | 6.05B | -3.31% | 874,662 | 769.10M |
| 138 | PACS | PACS Group, Inc. | 5.93B | -5.47% | 840,496 | 5.43B |
| 139 | PTCT | PTC Therapeutics, Inc. | 5.93B | -1.72% | 843,494 | 827.11M |
| 140 | SRRK | Scholar Rock Holding Corporation | 5.91B | -3.76% | 1,346,153 | - |
| 141 | CGON | CG Oncology, Inc. | 5.90B | -3.75% | 1,181,144 | 5.07M |
| 142 | RGEN | Repligen Corporation | 5.80B | -0.49% | 2,307,275 | 763.34M |
| 143 | HIMS | Hims & Hers Health, Inc. | 5.80B | 3.34% | 20,662,215 | 2.37B |
| 144 | CHE | Chemed Corporation | 5.74B | 1.95% | 268,840 | 2.54B |
| 145 | TFX | Teleflex Incorporated | 5.74B | -0.44% | 542,705 | 2.13B |
| 146 | BLCO | Bausch + Lomb Corporation | 5.74B | -1.11% | 450,877 | 5.21B |
| 147 | BLTE | Belite Bio, Inc | 5.63B | -4.63% | 256,584 | - |
| 148 | TGTX | TG Therapeutics, Inc. | 5.60B | -3.16% | 1,717,242 | 700.35M |
| 149 | IMVT | Immunovant, Inc. | 5.60B | -5.08% | 1,252,340 | - |
| 150 | COGT | Cogent Biosciences, Inc. | 5.59B | -4.42% | 2,079,024 | - |
| 151 | XENE | Xenon Pharmaceuticals Inc. | 5.26B | -2.87% | 610,338 | 7.50M |
| 152 | AVTR | Avantor, Inc. | 5.20B | -4.03% | 7,960,092 | 6.55B |
| 153 | LEGN | Legend Biotech Corporation | 5.12B | -3.67% | 1,800,248 | 1.14B |
| 154 | LQDA | Liquidia Corporation | 5.06B | -4.00% | 2,143,339 | 288.07M |
| 155 | STVN | Stevanato Group S.p.A. | 4.91B | - | 444,958 | 1.39B |
| 156 | DNTH | Dianthus Therapeutics, Inc. | 4.71B | 0.96% | 612,371 | 1.34M |
| 157 | CRSP | CRISPR Therapeutics AG | 4.67B | -4.04% | 1,978,748 | 4.10M |
| 158 | SHC | Sotera Health Company | 4.35B | -1.42% | 6,864,380 | 1.19B |
| 159 | KNSA | Kiniksa Pharmaceuticals International, plc | 4.35B | -3.47% | 471,517 | 754.05M |
| 160 | LGND | Ligand Pharmaceuticals Incorporated | 4.27B | -2.63% | 127,863 | 274.48M |
| 161 | HNGE | Hinge Health, Inc. | 4.22B | 1.15% | 1,097,152 | 646.34M |
| 162 | RDNT | RadNet, Inc. | 4.12B | -1.95% | 744,942 | 2.14B |
| 163 | CAI | Caris Life Sciences, Inc. | 4.11B | -4.59% | 4,696,984 | 907.29M |
| 164 | MANE | Veradermics, Incorporated | 4.11B | -5.99% | 476,746 | - |
| 165 | NAMS | NewAmsterdam Pharma Company N.V. | 4.07B | -3.90% | 1,132,497 | 22.57M |
| 166 | TVTX | Travere Therapeutics, Inc. | 3.96B | -3.42% | 1,650,992 | 536.20M |
| 167 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.88B | -4.02% | 1,108,963 | 18.07M |
| 168 | LIVN | LivaNova PLC | 3.85B | -2.33% | 568,467 | 1.43B |
| 169 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.82B | 0.06% | 2,300,142 | 596.96M |
| 170 | AMRX | Amneal Pharmaceuticals, Inc. | 3.81B | -2.45% | 1,331,984 | 3.05B |
| 171 | BLLN | BillionToOne, Inc. | 3.80B | -6.04% | 1,105,674 | 354.54M |
| 172 | NVST | Envista Holdings Corporation | 3.78B | -2.68% | 3,850,438 | 2.81B |
| 173 | IRTC | iRhythm Holdings, Inc. | 3.75B | -0.14% | 660,878 | 787.85M |
| 174 | ORKA | Oruka Therapeutics, Inc. | 3.74B | -3.08% | 1,392,947 | - |
| 175 | ACAD | ACADIA Pharmaceuticals Inc. | 3.66B | -3.12% | 1,292,645 | 1.10B |
| 176 | MMSI | Merit Medical Systems, Inc. | 3.66B | -1.92% | 722,893 | 1.54B |
| 177 | TLX | Telix Pharmaceuticals Limited | 3.57B | -2.76% | 80,248 | 803.79M |
| 178 | EWTX | Edgewise Therapeutics, Inc. | 3.56B | -2.71% | 989,175 | - |
| 179 | WRBY | Warby Parker Inc. | 3.53B | -0.59% | 4,084,080 | 890.57M |
| 180 | OGN | Organon & Co. | 3.52B | 0.30% | 3,280,035 | 6.16B |
| 181 | VKTX | Viking Therapeutics, Inc. | 3.51B | -4.54% | 1,769,998 | - |
| 182 | DOCS | Doximity, Inc. | 3.50B | 5.33% | 12,354,254 | 644.86M |
| 183 | WAY | Waystar Holding Corp. | 3.44B | -4.78% | 2,151,870 | 1.16B |
| 184 | CON | Concentra Group Holdings Parent, Inc. | 3.31B | -1.26% | 664,152 | 2.23B |
| 185 | ALHC | Alignment Healthcare, Inc. | 3.25B | -5.01% | 5,518,373 | 4.26B |
| 186 | ERAS | Erasca, Inc. | 3.18B | -1.35% | 3,333,522 | - |
| 187 | BKD | Brookdale Senior Living Inc. | 3.11B | -1.29% | 4,576,984 | 3.00B |
| 188 | VCYT | Veracyte, Inc. | 3.07B | -1.08% | 944,926 | 541.74M |
| 189 | OPCH | Option Care Health, Inc. | 3.07B | -2.16% | 3,146,316 | 5.67B |
| 190 | TWST | Twist Bioscience Corporation | 3.06B | -7.14% | 2,578,006 | 409.48M |
| 191 | MMED | MiniMed Group, Inc. | 3.03B | -2.53% | 577,967 | 2.99B |
| 192 | NHC | National HealthCare Corporation | 3.02B | -2.18% | 75,793 | 1.53B |
| 193 | ITGR | Integer Holdings Corporation | 2.99B | -1.85% | 390,437 | 1.86B |
| 194 | RCUS | Arcus Biosciences, Inc. | 2.99B | -4.69% | 968,198 | 236.00M |
| 195 | GMRS | GMR Solutions Inc. | 2.98B | -3.47% | 1,227,252 | 5.74B |
| 196 | TNGX | Tango Therapeutics, Inc. | 2.97B | -17.33% | 6,857,978 | 56.99M |
| 197 | ICUI | ICU Medical, Inc. | 2.97B | -3.47% | 316,429 | 2.16B |
| 198 | LFST | LifeStance Health Group, Inc. | 2.97B | -3.04% | 4,057,784 | 1.49B |
| 199 | DNLI | Denali Therapeutics Inc. | 2.96B | -3.97% | 2,154,160 | - |
| 200 | ALMS | Alumis Inc. | 2.92B | -7.15% | 943,726 | 8.40M |
| 201 | PRVA | Privia Health Group, Inc. | 2.89B | -1.25% | 947,784 | 2.25B |
| 202 | SUPN | Supernus Pharmaceuticals, Inc. | 2.87B | -3.46% | 616,053 | 776.83M |
| 203 | DYN | Dyne Therapeutics, Inc. | 2.86B | -5.42% | 1,197,249 | - |
| 204 | BEAM | Beam Therapeutics Inc. | 2.78B | -5.42% | 2,010,429 | 164.01M |
| 205 | SLNO | Soleno Therapeutics, Inc. | 2.76B | 0.04% | 4,968,835 | 285.01M |
| 206 | GPCR | Structure Therapeutics Inc. | 2.75B | -2.89% | 467,336 | - |
| 207 | KLRA | Kailera Therapeutics, Inc. | 2.73B | -2.14% | 482,223 | - |
| 208 | TXG | 10x Genomics, Inc. | 2.69B | -1.49% | 2,731,063 | 638.78M |
| 209 | TARS | Tarsus Pharmaceuticals, Inc. | 2.69B | -4.14% | 720,844 | 535.08M |
| 210 | VERA | Vera Therapeutics, Inc. | 2.68B | -5.66% | 1,034,617 | - |
| 211 | ARQT | Arcutis Biotherapeutics, Inc. | 2.67B | -1.16% | 1,600,525 | 415.62M |
| 212 | HAE | Haemonetics Corporation | 2.62B | -1.45% | 911,906 | 1.33B |
| 213 | GRAL | GRAIL, Inc. | 2.56B | -3.48% | 642,473 | 156.12M |
| 214 | IRON | Disc Medicine, Inc. | 2.55B | -4.07% | 825,263 | - |
| 215 | ELVN | Enliven Therapeutics, Inc. | 2.52B | -4.04% | 500,944 | - |
| 216 | IDYA | IDEAYA Biosciences, Inc. | 2.48B | -2.18% | 867,842 | 225.27M |
| 217 | NBTX | Nanobiotix S.A. | 2.47B | -6.48% | 88,651 | 38.27M |
| 218 | CLDX | Celldex Therapeutics, Inc. | 2.46B | -3.42% | 682,147 | 865.00K |
| 219 | RARE | Ultragenyx Pharmaceutical Inc. | 2.45B | -3.10% | 1,519,285 | 670.00M |
| 220 | HTFL | HeartFlow, Inc. | 2.44B | -12.17% | 2,009,123 | 191.42M |
| 221 | NKTR | Nektar Therapeutics | 2.38B | -4.99% | 1,272,965 | 55.63M |
| 222 | ACHC | Acadia Healthcare Company, Inc. | 2.37B | -3.69% | 1,222,183 | 3.37B |
| 223 | IMNM | Immunome, Inc. | 2.36B | -5.18% | 1,309,846 | 4.02M |
| 224 | RLAY | Relay Therapeutics, Inc. | 2.34B | -4.54% | 2,470,004 | 10.68M |
| 225 | GRDN | Guardian Pharmacy Services, Inc. | 2.32B | 0.94% | 506,989 | 1.46B |
| 226 | ZLAB | Zai Lab Limited | 2.31B | 1.28% | 903,115 | 453.28M |
| 227 | KOD | Kodiak Sciences Inc. | 2.31B | -4.34% | 812,494 | - |
| 228 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.29B | -5.75% | 4,576,465 | 885.72M |
| 229 | DFTX | Definium Therapeutics, Inc. | 2.29B | -1.69% | 1,435,670 | - |
| 230 | MLYS | Mineralys Therapeutics, Inc. | 2.26B | 0.40% | 964,339 | - |
| 231 | LMAT | LeMaitre Vascular, Inc. | 2.22B | -2.20% | 201,822 | 256.28M |
| 232 | PBH | Prestige Consumer Healthcare Inc. | 2.21B | 1.79% | 2,000,445 | 1.09B |
| 233 | TYRA | Tyra Biosciences, Inc. | 2.20B | 1.45% | 1,017,792 | - |
| 234 | TMDX | TransMedics Group, Inc. | 2.18B | 1.87% | 1,221,191 | 635.89M |
| 235 | AXGN | Axogen, Inc. | 2.18B | 0.10% | 1,029,074 | 238.11M |
| 236 | HCM | HUTCHMED (China) Limited | 2.12B | -1.42% | 20,995 | 548.51M |
| 237 | ADPT | Adaptive Biotechnologies Corporation | 2.05B | -2.66% | 1,563,598 | 295.41M |
| 238 | SEM | Select Medical Holdings Corporation | 2.05B | 0.24% | 1,603,539 | 5.52B |
| 239 | GENB | Generate Biomedicines, Inc. | 2.04B | 3.43% | 1,442,599 | 30.30M |
| 240 | NVCR | NovoCure Limited | 2.04B | -2.60% | 1,408,670 | 674.41M |
| 241 | BHC | Bausch Health Companies Inc. | 2.02B | -0.55% | 1,037,203 | 10.53B |
| 242 | XRAY | DENTSPLY SIRONA Inc. | 2.02B | -3.27% | 9,073,378 | 3.68B |
| 243 | TRVI | Trevi Therapeutics, Inc. | 2.02B | -5.84% | 896,407 | - |
| 244 | OCUL | Ocular Therapeutix, Inc. | 2.01B | -3.58% | 2,373,738 | 52.04M |
| 245 | PHVS | Pharvaris N.V. | 1.99B | -0.98% | 444,227 | - |
| 246 | AUPH | Aurinia Pharmaceuticals Inc. | 1.97B | -3.54% | 1,112,289 | 298.30M |
| 247 | OMCL | Omnicell, Inc. | 1.96B | -1.55% | 549,736 | 1.23B |
| 248 | ESTA | Establishment Labs Holdings Inc. | 1.93B | -5.79% | 532,859 | 229.58M |
| 249 | ADMA | ADMA Biologics, Inc. | 1.92B | -2.71% | 3,718,908 | 509.86M |
| 250 | NTLA | Intellia Therapeutics, Inc. | 1.91B | 4.43% | 14,834,402 | 66.09M |
| 251 | ASTH | Astrana Health, Inc. | 1.90B | -2.30% | 373,874 | 3.53B |
| 252 | MESO | Mesoblast Limited | 1.89B | -0.60% | 162,027 | 65.38M |
| 253 | STOK | Stoke Therapeutics, Inc. | 1.87B | -4.08% | 673,587 | 32.08M |
| 254 | SRPT | Sarepta Therapeutics, Inc. | 1.85B | -6.05% | 4,571,083 | 2.18B |
| 255 | ANAB | AnaptysBio, Inc. | 1.84B | 1.54% | 448,356 | 232.39M |
| 256 | CLOV | Clover Health Investments, Corp. | 1.83B | -0.57% | 10,672,037 | 2.21B |
| 257 | PGNY | Progyny, Inc. | 1.82B | 1.66% | 945,115 | 1.29B |
| 258 | SION | Sionna Therapeutics, Inc. | 1.82B | -5.96% | 273,180 | - |
| 259 | SGRY | Surgery Partners, Inc. | 1.81B | -3.66% | 1,491,341 | 3.34B |
| 260 | MD | Pediatrix Medical Group, Inc. | 1.80B | -4.22% | 888,927 | 1.93B |
| 261 | SNDX | Syndax Pharmaceuticals, Inc. | 1.79B | -1.56% | 1,842,903 | 217.17M |
| 262 | OCS | Oculis Holding AG | 1.79B | 0.23% | 250,915 | 1.40M |
| 263 | LKFT | Lakefront Biotherapeutics NV | 1.79B | -1.60% | 152,082 | 1.20B |
| 264 | NEOG | Neogen Corporation | 1.78B | -2.85% | 1,515,326 | 870.56M |
| 265 | RAPP | Rapport Therapeutics, Inc. | 1.77B | -2.32% | 230,888 | 20.00M |
| 266 | AAPG | Ascentage Pharma Group International | 1.77B | -3.37% | 29,166 | 82.08M |
| 267 | SNDA | Sonida Senior Living, Inc. | 1.76B | -2.07% | 496,427 | 367.34M |
| 268 | ZYME | Zymeworks Inc. | 1.75B | -0.13% | 640,796 | 81.26M |
| 269 | HRMY | Harmony Biosciences Holdings, Inc. | 1.74B | -2.18% | 471,145 | 899.11M |
| 270 | VRDN | Viridian Therapeutics, Inc. | 1.73B | -3.50% | 1,614,544 | 70.92M |
| 271 | TSHA | Taysha Gene Therapies, Inc. | 1.71B | -5.40% | 3,250,668 | 7.47M |
| 272 | QURE | uniQure N.V. | 1.71B | -2.52% | 1,450,296 | 18.09M |
| 273 | PLSE | Pulse Biosciences, Inc. | 1.70B | -9.41% | 570,713 | 751.00K |
| 274 | VCEL | Vericel Corporation | 1.69B | -0.33% | 448,985 | 292.09M |
| 275 | AVAH | Aveanna Healthcare Holdings Inc. | 1.68B | 3.76% | 3,574,857 | 2.52B |
| 276 | AGIO | Agios Pharmaceuticals, Inc. | 1.68B | -1.95% | 604,084 | 66.05M |
| 277 | CAPR | Capricor Therapeutics, Inc. | 1.67B | -3.42% | 988,779 | 11.13M |
| 278 | ADUS | Addus HomeCare Corporation | 1.66B | -1.55% | 304,582 | 1.45B |
| 279 | UFPT | UFP Technologies, Inc. | 1.66B | -3.16% | 263,619 | 608.85M |
| 280 | ANIP | ANI Pharmaceuticals, Inc. | 1.65B | -1.97% | 324,963 | 923.71M |
| 281 | NRIX | Nurix Therapeutics, Inc. | 1.64B | -0.91% | 1,000,309 | 71.78M |
| 282 | PVLA | Palvella Therapeutics, Inc. | 1.64B | -3.98% | 258,449 | - |
| 283 | INVA | Innoviva, Inc. | 1.62B | -3.89% | 1,002,579 | 420.69M |
| 284 | STAA | STAAR Surgical Company | 1.60B | 0.19% | 1,372,899 | 290.38M |
| 285 | INBX | Inhibrx Biosciences, Inc. | 1.59B | -6.47% | 394,324 | 1.30M |
| 286 | PGEN | Precigen, Inc. | 1.58B | -3.91% | 3,615,522 | 31.60M |
| 287 | RXRX | Recursion Pharmaceuticals, Inc. | 1.56B | -3.62% | 17,432,059 | 66.41M |
| 288 | MBX | MBX Biosciences, Inc. | 1.54B | -8.23% | 606,377 | - |
| 289 | IOVA | Iovance Biotherapeutics, Inc. | 1.54B | -1.99% | 7,853,228 | 285.61M |
| 290 | ARDX | Ardelyx, Inc. | 1.54B | -3.56% | 3,244,107 | 427.68M |
| 291 | GLUE | Monte Rosa Therapeutics, Inc. | 1.53B | -2.84% | 926,125 | 42.95M |
| 292 | NUVB | Nuvation Bio Inc. | 1.50B | -8.47% | 8,030,763 | 143.05M |
| 293 | ALMR | Alamar Biosciences, Inc. | 1.49B | -4.31% | 253,190 | 87.16M |
| 294 | NVAX | Novavax, Inc. | 1.49B | -3.10% | 4,070,808 | 596.34M |
| 295 | PRCT | PROCEPT BioRobotics Corporation | 1.49B | -0.99% | 2,135,644 | 322.02M |
| 296 | DMRA | Damora Therapeutics, Inc. | 1.48B | 3.02% | 439,599 | - |
| 297 | VIR | Vir Biotechnology, Inc. | 1.48B | -3.30% | 1,714,436 | 65.50M |
| 298 | AHG | Akso Health Group | 1.48B | -15.20% | 85,503 | 14.84M |
| 299 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.48B | -4.29% | 998,049 | -665.00K |
| 300 | ATAI | AtaiBeckley Inc. | 1.47B | -0.62% | 2,885,868 | 3.49M |
| 301 | PRGO | Perrigo Company plc | 1.47B | -2.12% | 2,437,220 | 4.18B |
| 302 | GHRS | GH Research PLC | 1.47B | -3.69% | 201,146 | - |
| 303 | HCSG | Healthcare Services Group, Inc. | 1.46B | -1.67% | 426,764 | 1.85B |
| 304 | IMTX | Immatics N.V. | 1.46B | -2.69% | 358,337 | 43.00M |
| 305 | ARDT | Ardent Health, Inc. | 1.45B | -2.13% | 519,083 | 6.43B |
| 306 | IMCR | Immunocore Holdings plc | 1.43B | -2.47% | 194,929 | 412.81M |
| 307 | ATRC | AtriCure, Inc. | 1.42B | -0.11% | 1,036,886 | 552.16M |
| 308 | KALV | KalVista Pharmaceuticals, Inc. | 1.42B | -0.11% | 8,869,863 | 114.48M |
| 309 | AHCO | AdaptHealth Corp. | 1.42B | -0.74% | 1,130,695 | 3.29B |
| 310 | MAZE | Maze Therapeutics, Inc. | 1.41B | -3.29% | 411,801 | 20.00M |
| 311 | URGN | UroGen Pharma Ltd. | 1.40B | -3.03% | 944,066 | 140.49M |
| 312 | CMPS | COMPASS Pathways plc | 1.40B | -2.35% | 3,132,837 | - |
| 313 | ENOV | Enovis Corporation | 1.40B | -7.01% | 1,262,382 | 2.28B |
| 314 | PAHC | Phibro Animal Health Corporation | 1.39B | -4.92% | 475,690 | 1.50B |
| 315 | AGL | agilon health, inc. | 1.36B | 4.13% | 443,977 | 5.82B |
| 316 | BCAX | Bicara Therapeutics Inc. | 1.33B | -2.03% | 552,932 | - |
| 317 | BHVN | Biohaven Ltd. | 1.32B | -2.88% | 2,023,031 | - |
| 318 | SLS | SELLAS Life Sciences Group, Inc. | 1.32B | -4.58% | 8,554,329 | - |
| 319 | MPLT | MapLight Therapeutics, Inc. | 1.30B | -1.91% | 176,880 | - |
| 320 | WVE | Wave Life Sciences Ltd. | 1.30B | -1.88% | 4,227,027 | 71.80M |
| 321 | AVBP | ArriVent BioPharma, Inc. | 1.30B | -1.94% | 278,477 | - |
| 322 | FTRE | Fortrea Holdings Inc. | 1.29B | -4.07% | 1,100,932 | 2.71B |
| 323 | MLTX | MoonLake Immunotherapeutics | 1.28B | -4.57% | 585,569 | - |
| 324 | SVRA | Savara Inc. | 1.28B | -4.55% | 2,510,784 | - |
| 325 | ABCL | AbCellera Biologics Inc. | 1.25B | -7.05% | 8,869,939 | 79.21M |
| 326 | AVLN | Avalyn Pharma Inc. | 1.25B | -2.55% | 205,029 | - |
| 327 | COAG | Hemab Therapeutics Holdings, Inc. | 1.24B | -1.06% | 118,340 | - |
| 328 | PNTG | The Pennant Group, Inc. | 1.24B | -3.66% | 402,544 | 1.02B |
| 329 | SEPN | Septerna, Inc. | 1.21B | -4.84% | 573,806 | 72.26M |
| 330 | WGS | GeneDx Holdings Corp. | 1.21B | 4.89% | 1,630,347 | 442.68M |
| 331 | OLMA | Olema Pharmaceuticals, Inc. | 1.19B | -1.66% | 1,223,932 | - |
| 332 | NNNN | Anbio Biotechnology | 1.18B | 7.46% | 19,833 | 8.65M |
| 333 | ATEC | Alphatec Holdings, Inc. | 1.18B | 1.19% | 2,883,592 | 787.08M |
| 334 | HROW | Harrow, Inc. | 1.16B | 1.13% | 1,200,328 | 268.68M |
| 335 | IVA | Inventiva S.A. | 1.16B | -1.98% | 284,639 | 7.94M |
| 336 | ZBIO | Zenas BioPharma, Inc. | 1.16B | -2.96% | 642,859 | 10.00M |
| 337 | AVNS | Avanos Medical, Inc. | 1.16B | - | 592,052 | 715.90M |
| 338 | KMTS | Kestra Medical Technologies, Ltd. | 1.16B | -10.19% | 329,132 | 83.72M |
| 339 | INSP | Inspire Medical Systems, Inc. | 1.15B | -6.12% | 1,676,523 | 915.25M |
| 340 | JBIO | Jade Biosciences, Inc. | 1.15B | -3.21% | 555,324 | - |
| 341 | DBVT | DBV Technologies S.A. | 1.15B | -0.96% | 66,968 | 5.74M |
| 342 | TDOC | Teladoc Health, Inc. | 1.15B | -3.78% | 4,380,825 | 2.51B |
| 343 | AMN | AMN Healthcare Services, Inc. | 1.11B | -5.58% | 1,120,093 | 3.42B |
| 344 | AORT | Artivion, Inc. | 1.11B | -0.70% | 863,969 | 458.69M |
| 345 | IRMD | IRADIMED CORPORATION | 1.10B | -0.29% | 182,195 | 86.28M |
| 346 | IART | Integra LifeSciences Holdings Corporation | 1.10B | -2.76% | 864,782 | 1.64B |
| 347 | COLL | Collegium Pharmaceutical, Inc. | 1.10B | -3.01% | 307,777 | 796.33M |
| 348 | AKTS | Aktis Oncology, Inc. | 1.08B | 0.26% | 142,841 | 8.28M |
| 349 | XERS | Xeris Biopharma Holdings, Inc. | 1.08B | -2.19% | 1,222,570 | 314.85M |
| 350 | NEO | NeoGenomics, Inc. | 1.07B | -1.44% | 1,112,186 | 745.97M |
| 351 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.07B | -3.26% | 1,538,467 | 204.73M |
| 352 | CNMD | CONMED Corporation | 1.07B | -2.34% | 384,786 | 1.37B |
| 353 | ALVO | Alvotech | 1.04B | -3.50% | 683,786 | 562.04M |
| 354 | EYPT | EyePoint, Inc. | 1.04B | -6.72% | 538,881 | 7.61M |
| 355 | CRVS | Corvus Pharmaceuticals, Inc. | 1.04B | -9.88% | 3,488,797 | - |
| 356 | CDNA | CareDx, Inc. | 1.03B | -2.54% | 637,608 | 412.82M |
| 357 | BLFS | BioLife Solutions, Inc. | 1.01B | -1.42% | 375,002 | 101.66M |
| 358 | BFLY | Butterfly Network, Inc. | 1.00B | -6.59% | 4,187,977 | 102.92M |
| 359 | LXRX | Lexicon Pharmaceuticals, Inc. | 990.35M | -4.29% | 2,117,562 | 69.64M |
| 360 | CRON | Cronos Group Inc. | 987.05M | -4.01% | 3,907,314 | 159.54M |
| 361 | OMDA | Omada Health, Inc. | 984.47M | -0.12% | 1,336,649 | 283.30M |
| 362 | CGEM | Cullinan Therapeutics, Inc. | 966.74M | -2.60% | 766,859 | - |
| 363 | INNV | InnovAge Holding Corp. | 966.44M | -4.17% | 194,631 | 949.17M |
| 364 | USPH | U.S. Physical Therapy, Inc. | 955.89M | -3.50% | 354,912 | 787.69M |
| 365 | MNKD | MannKind Corporation | 954.66M | -4.04% | 4,962,234 | 360.78M |
| 366 | EVO | Evotec SE | 953.92M | -0.74% | 43,555 | 859.03M |
| 367 | PHAT | Phathom Pharmaceuticals, Inc. | 942.84M | -9.04% | 1,111,117 | 204.89M |
| 368 | DRTS | Alpha Tau Medical Ltd. | 911.78M | -0.48% | 901,305 | - |
| 369 | PHAR | Pharming Group N.V. | 910.21M | -0.31% | 4,842 | 369.49M |
| 370 | DSGN | Design Therapeutics, Inc. | 897.51M | -1.17% | 623,614 | - |
| 371 | SDGR | Schrödinger, Inc. | 892.91M | -5.31% | 1,181,644 | 254.91M |
| 372 | SPTX | Seaport Therapeutics, Inc. | 891.13M | -0.80% | 611,625 | - |
| 373 | PCRX | Pacira BioSciences, Inc. | 890.84M | -3.78% | 449,832 | 734.86M |
| 374 | OMER | Omeros Corporation | 886.60M | -7.76% | 3,266,355 | 9.89M |
| 375 | BVS | Bioventus Inc. | 883.80M | -0.28% | 710,390 | 576.30M |
| 376 | INMD | InMode Ltd. | 880.69M | -1.07% | 773,429 | 374.64M |
| 377 | TNDM | Tandem Diabetes Care, Inc. | 878.54M | -9.40% | 6,098,286 | 1.03B |
| 378 | TALK | Talkspace, Inc. | 871.07M | 0.19% | 1,618,960 | 238.37M |
| 379 | MGTX | MeiraGTx Holdings plc | 870.53M | -5.53% | 768,589 | 79.76M |
| 380 | AVTX | Avalo Therapeutics, Inc. | 870.26M | -6.68% | 1,534,181 | 59.00K |
| 381 | NUTX | Nutex Health Inc. | 869.11M | -1.20% | 98,116 | 879.95M |
| 382 | SANA | Sana Biotechnology, Inc. | 854.36M | -2.23% | 3,701,754 | - |
| 383 | AURA | Aura Biosciences, Inc. | 853.72M | -3.01% | 491,722 | - |
| 384 | ANNX | Annexon, Inc. | 853.62M | -2.98% | 1,850,636 | - |
| 385 | LBRX | LB Pharmaceuticals Inc | 850.55M | -5.57% | 255,967 | - |
| 386 | JANX | Janux Therapeutics, Inc. | 847.07M | -3.47% | 737,323 | 13.73M |
| 387 | ORIC | ORIC Pharmaceuticals, Inc. | 843.67M | -2.28% | 1,205,008 | - |
| 388 | ABUS | Arbutus Biopharma Corporation | 837.56M | -2.53% | 1,410,840 | 191.45M |
| 389 | TBPH | Theravance Biopharma, Inc. | 836.19M | -1.76% | 556,157 | 109.78M |
| 390 | XNCR | Xencor, Inc. | 831.87M | -5.56% | 895,183 | 97.36M |
| 391 | ODTX | Odyssey Therapeutics, Inc. | 831.21M | 1.73% | 405,163 | 2.98M |
| 392 | OPK | OPKO Health, Inc. | 830.60M | - | 2,667,320 | 581.12M |
| 393 | ETON | Eton Pharmaceuticals, Inc. | 828.89M | 1.00% | 543,176 | 86.93M |
| 394 | GERN | Geron Corporation | 827.56M | -7.86% | 16,158,372 | 196.12M |
| 395 | EVMN | Evommune, Inc. | 825.54M | 0.88% | 484,096 | 10.00M |
| 396 | GDRX | GoodRx Holdings, Inc. | 822.98M | -2.41% | 1,382,316 | 787.89M |
| 397 | KURA | Kura Oncology, Inc. | 818.50M | -5.34% | 1,516,362 | 71.64M |
| 398 | ANRO | Alto Neuroscience, Inc. | 805.51M | -2.59% | 376,330 | - |
| 399 | ESPR | Esperion Therapeutics, Inc. | 803.19M | - | 8,135,536 | 418.24M |
| 400 | ABSI | Absci Corporation | 799.79M | -7.40% | 4,088,723 | 1.84M |
| 401 | VOR | Vor Biopharma Inc. | 792.74M | -2.92% | 649,910 | - |
| 402 | CTMX | CytomX Therapeutics, Inc. | 785.91M | -4.50% | 3,924,061 | 35.54M |
| 403 | BIOA | BioAge Labs, Inc. | 785.04M | -5.66% | 481,581 | 10.32M |
| 404 | SGP | SpyGlass Pharma, Inc. | 775.83M | -4.37% | 34,905 | - |
| 405 | SSII | SS Innovations International, Inc. | 771.77M | -3.26% | 39,939 | 48.47M |
| 406 | AMPH | Amphastar Pharmaceuticals, Inc. | 743.85M | -2.49% | 679,289 | 720.53M |
| 407 | AZTA | Azenta, Inc. | 738.41M | -4.64% | 1,401,701 | 596.48M |
| 408 | SPRY | ARS Pharmaceuticals, Inc. | 737.33M | -6.49% | 3,673,513 | 98.99M |
| 409 | DRUG | Bright Minds Biosciences Inc. | 728.19M | -0.22% | 269,882 | - |
| 410 | RLMD | Relmada Therapeutics, Inc. | 723.73M | -7.01% | 1,440,736 | - |
| 411 | EIKN | Eikon Therapeutics, Inc. | 717.34M | 0.53% | 377,624 | - |
| 412 | TENX | Tenax Therapeutics, Inc. | 705.36M | 0.67% | 775,405 | - |
| 413 | QDEL | QuidelOrtho Corporation | 703.73M | -9.39% | 2,451,288 | 2.66B |
| 414 | CERT | Certara, Inc. | 696.93M | -2.82% | 3,042,768 | 419.75M |
| 415 | ALLO | Allogene Therapeutics, Inc. | 690.31M | -6.54% | 7,668,856 | 22.00K |
| 416 | AVR | Anteris Technologies Global Corp. | 684.71M | -0.14% | 1,027,828 | 1.85M |
| 417 | SLDB | Solid Biosciences Inc. | 681.27M | -9.31% | 2,022,293 | - |
| 418 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 681.08M | - | 816,017 | - |
| 419 | LMRI | Lumexa Imaging Holdings, Inc. | 675.45M | -2.50% | 2,949,205 | 1.03B |
| 420 | PSNL | Personalis, Inc. | 666.03M | -5.22% | 1,773,845 | 64.52M |
| 421 | CBIO | Crescent Biopharma, Inc. | 663.58M | -5.93% | 260,486 | 11.88M |
| 422 | HSTM | HealthStream, Inc. | 663.18M | -0.39% | 430,972 | 311.78M |
| 423 | ZVRA | Zevra Therapeutics, Inc. | 650.86M | -5.57% | 1,728,332 | 122.29M |
| 424 | STRO | Sutro Biopharma, Inc. | 645.65M | 1.43% | 261,210 | 99.61M |
| 425 | CADL | Candel Therapeutics, Inc. | 642.58M | -1.57% | 3,683,150 | - |
| 426 | TLRY | Tilray Brands, Inc. | 634.58M | -3.27% | 4,339,270 | 858.28M |
| 427 | BWAY | BrainsWay Ltd. | 632.37M | -7.90% | 261,867 | 56.22M |
| 428 | ACRS | Aclaris Therapeutics, Inc. | 631.28M | -5.83% | 929,252 | 8.37M |
| 429 | SIBN | SI-BONE, Inc. | 627.99M | -3.01% | 763,654 | 206.22M |
| 430 | CBLL | CeriBell, Inc. | 618.47M | -0.97% | 387,013 | 95.07M |
| 431 | GYRE | Gyre Therapeutics, Inc. | 598.49M | -6.43% | 94,306 | 117.05M |
| 432 | CRMD | CorMedix Inc. | 592.31M | -4.79% | 2,835,693 | 400.05M |
| 433 | TRAX | First Tracks Biotherapeutics, Inc. | 589.68M | -6.94% | 196,058 | - |
| 434 | IRWD | Ironwood Pharmaceuticals, Inc. | 589.32M | -2.45% | 2,175,029 | 361.51M |
| 435 | FBRX | Forte Biosciences, Inc. | 586.10M | -3.55% | 177,695 | - |
| 436 | ARVN | Arvinas, Inc. | 585.85M | -3.61% | 968,098 | 89.40M |
| 437 | CSTL | Castle Biosciences, Inc. | 580.21M | 1.32% | 554,910 | 339.92M |
| 438 | KYTX | Kyverna Therapeutics, Inc. | 574.43M | -11.64% | 1,195,417 | - |
| 439 | ALT | Altimmune, Inc. | 554.25M | -2.40% | 2,286,910 | 36.00K |
| 440 | VALN | Valneva SE | 545.03M | -4.38% | 25,873 | 180.25M |
| 441 | ACHV | Achieve Life Sciences, Inc. | 543.07M | -8.64% | 1,295,496 | - |
| 442 | ANL | Adlai Nortye Ltd. | 540.40M | -2.53% | 90,733 | 5.00M |
| 443 | CABA | Cabaletta Bio, Inc. | 539.69M | -8.31% | 3,192,918 | - |
| 444 | RIGL | Rigel Pharmaceuticals, Inc. | 536.75M | -9.12% | 500,513 | 299.77M |
| 445 | PHR | Phreesia, Inc. | 532.89M | - | 1,550,936 | 480.59M |
| 446 | MDXG | MiMedx Group, Inc. | 530.25M | 0.28% | 1,221,195 | 389.42M |
| 447 | PRME | Prime Medicine, Inc. | 529.21M | -6.39% | 3,114,619 | 4.03M |
| 448 | IMMX | Immix Biopharma, Inc. | 526.94M | -1.58% | 603,256 | - |
| 449 | TECX | Tectonic Therapeutic, Inc. | 526.26M | -6.41% | 298,095 | - |
| 450 | NPCE | NeuroPace, Inc. | 523.68M | -2.72% | 129,986 | 99.53M |
| 451 | XOMA | XOMA Royalty Corporation | 523.59M | -0.60% | 102,505 | 48.56M |
| 452 | AQST | Aquestive Therapeutics, Inc. | 523.13M | -11.84% | 3,419,764 | 50.27M |
| 453 | AGMB | AgomAb Therapeutics NV | 519.57M | -4.44% | 42,831 | - |
| 454 | CLYM | Climb Bio, Inc. | 515.90M | -4.68% | 655,308 | - |
| 455 | CTNM | Contineum Therapeutics, Inc. | 512.94M | -3.45% | 181,201 | - |
| 456 | TCMD | Tactile Systems Technology, Inc. | 512.93M | -1.30% | 331,469 | 343.52M |
| 457 | PRTA | Prothena Corporation plc | 510.97M | -1.01% | 700,064 | 57.94M |
| 458 | MCTA | Charming Medical Limited | 504.26M | -0.85% | 4,251,392 | 5.42M |
| 459 | DNA | Ginkgo Bioworks Holdings, Inc. | 503.65M | -1.78% | 1,045,746 | 151.40M |
| 460 | PROK | ProKidney Corp. | 501.26M | -2.92% | 884,535 | 889.00K |
| 461 | UPB | Upstream Bio, Inc. | 494.68M | 3.41% | 979,925 | 3.32M |
| 462 | OFIX | Orthofix Medical Inc. | 485.46M | -2.28% | 221,527 | 825.37M |
| 463 | FDMT | 4D Molecular Therapeutics, Inc. | 478.33M | -6.73% | 574,828 | 88.24M |
| 464 | ARTV | Artiva Biotherapeutics, Inc. | 475.19M | -8.43% | 524,525 | 251.00K |
| 465 | STTK | Shattuck Labs, Inc. | 473.14M | -6.15% | 265,422 | 1.00M |
| 466 | NGNE | Neurogene Inc. | 471.21M | -4.64% | 87,509 | 925.00K |
| 467 | OCGN | Ocugen, Inc. | 470.55M | -4.79% | 4,785,061 | 4.47M |
| 468 | CERS | Cerus Corporation | 468.86M | -6.77% | 2,622,455 | 216.56M |
| 469 | KMDA | Kamada Ltd. | 463.82M | -3.99% | 65,815 | 181.68M |
| 470 | ASMB | Assembly Biosciences, Inc. | 455.32M | -5.45% | 122,208 | 71.10M |
| 471 | KIDS | OrthoPediatrics Corp. | 455.14M | -1.01% | 136,670 | 243.30M |
| 472 | OVID | Ovid Therapeutics Inc. | 455.09M | -6.07% | 1,252,596 | 7.12M |
| 473 | SRTA | Strata Critical Medical, Inc. | 451.67M | -4.57% | 1,048,173 | 228.58M |
| 474 | PRLD | Prelude Therapeutics Incorporated | 450.59M | 0.22% | 472,175 | 16.72M |
| 475 | ANGO | AngioDynamics, Inc. | 448.92M | -2.36% | 245,942 | 313.73M |
| 476 | ZURA | Zura Bio Limited | 447.84M | -2.28% | 525,747 | - |
| 477 | FLGT | Fulgent Genetics, Inc. | 445.89M | -3.03% | 471,566 | 320.35M |
| 478 | FULC | Fulcrum Therapeutics, Inc. | 445.78M | -5.91% | 431,144 | 80.00M |
| 479 | EVH | Evolent Health, Inc. | 445.43M | -3.41% | 2,847,166 | 1.89B |
| 480 | VTVT | vTv Therapeutics Inc. | 442.96M | -7.12% | 46,241 | 36.84M |
| 481 | CTKB | Cytek Biosciences, Inc. | 439.73M | 1.49% | 1,622,110 | 204.17M |
| 482 | CATX | Perspective Therapeutics, Inc. | 439.08M | -0.26% | 885,278 | 618.00K |
| 483 | AUTL | Autolus Therapeutics plc | 433.81M | 2.52% | 1,482,827 | 92.62M |
| 484 | REPL | Replimune Group, Inc. | 431.03M | 5.88% | 5,875,124 | - |
| 485 | EOLS | Evolus, Inc. | 428.06M | -1.22% | 559,756 | 301.79M |
| 486 | PRTC | PureTech Health plc | 427.39M | -3.17% | 5,464 | 4.66M |
| 487 | EPRX | Eupraxia Pharmaceuticals Inc. | 426.36M | -3.35% | 187,175 | - |
| 488 | SGMT | Sagimet Biosciences Inc. | 426.09M | -6.38% | 744,646 | - |
| 489 | CCRN | Cross Country Healthcare, Inc. | 424.53M | - | 593,942 | 1.00B |
| 490 | IPSC | Century Therapeutics, Inc. | 422.03M | -1.68% | 751,263 | 109.16M |
| 491 | BBNX | Beta Bionics, Inc. | 421.55M | 2.83% | 906,254 | 110.24M |
| 492 | WEAV | Weave Communications, Inc. | 420.11M | 2.52% | 1,073,773 | 248.72M |
| 493 | NRC | NRC Health | 419.63M | -1.64% | 120,110 | 138.64M |
| 494 | LYEL | Lyell Immunopharma, Inc. | 418.12M | -5.78% | 107,622 | 31.00K |
| 495 | ADCT | ADC Therapeutics SA | 413.37M | -3.27% | 1,103,266 | 79.18M |
| 496 | EBS | Emergent BioSolutions Inc. | 409.67M | -3.29% | 508,196 | 676.80M |
| 497 | VREX | Varex Imaging Corporation | 407.14M | -3.59% | 696,718 | 857.50M |
| 498 | LXEO | Lexeo Therapeutics, Inc. | 399.68M | -7.45% | 787,573 | - |
| 499 | TOI | The Oncology Institute, Inc. | 397.93M | -1.49% | 1,049,390 | 545.76M |
| 500 | MNPR | Monopar Therapeutics Inc. | 397.04M | -2.82% | 135,508 | - |